Build your own keyword analysis with our tools
SEO Report
Server Infos
Backlinks

HTML Analysis

Page Status
 

Found

Highlighted Content
Title

Aptalis

Description

Keywords

H1

Aptalis Pharma Begins Promotion of RECTIV™ to Physicians in the U.S.
Aptalis Pharma Announces FDA Approval of ULTRESA™ Pancrelipase Delayed Release Capsules and VIOKACE™ Pancrelipase Tablets
Aptalis Pharmaceutical Technologies
Aptalis Pharma™ Launches PYLERA ® in France: A Therapeutic Alternative for Eradicating Helicobacter Pylori and Preventing Relapse of H. Pylori Associated Peptic Ulcers

H2

Adverse Reporting
Quick Links

H3

H4

H5

Text Analysis

Cloud of Keywords from all content
High relevance
 

aptalis pharma pharmaceutical

Medium relevance
 

technologies contact

Low relevance
 

technologies contact products map adverse fda business release pylera france development pylori pancrelipase

Very Low relevance
 
products map adverse fda business release pylera france development pylori pancrelipase ulcers bridgewater marketwired apr peptic announced nj-- eradicating therapeutic launches alternative french preventing helicobacter relapse press california policy privacy declaration code june updated conduct last conditions terms healthcare launched company professionals click reserved rights pharma&trade sister 472-2634 delayed ultresa&trade approval capsules viokace&trade develops technology tablets announces physicians events news franais pipeline careers rectiv&trade promotion manufactures enhanced 809-4950 service 1-800-fda-1088 customer canada links press jobs about store grants search releases online 1-800-472-2634 reactions proprietary range based oral reporting to suspected report gastroenterology glossary aptalis

Highlighted Content Analysis

Cloud of Keywords from all content
High relevance
 

aptalis

Medium relevance
 

Low relevance
 

pylori pancrelipase pharma

Very Low relevance
 
pylori pancrelipase pharma helicobacter eradicating france pylera therapeutic alternative preventing reporting links adverse ulcers relapse peptic launches technologies fda approval announces physicians promotion rectiv&trade ultresa&trade delayed tablets pharmaceutical viokace&trade capsules release pharma&trade